Overview

Indigo Naturalis in Treating Atopic Dermatitis Topically

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Atopic dermatitis (AD) is a chronic inflammatory skin disorder that most commonly occurs in children. The aims of this project are: 1. To evaluate the efficacy of indigo naturalis ointment in treating AD topically; 2. To evaluate the safety of indigo naturalis ointment in treating AD topically; 3. To investigate whether indigo naturalis ointment treatment is associated with a change in total IgE, cytokines, eosinophils, and CRP in patients with AD; 4. To evaluate whether indigo naturalis ointment treatment improves the quality of life in patients with AD.
Phase:
Phase 2
Details
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborator:
Ministry of Science and Technology, Taiwan